Glaxosmithkline

CSL Behring is one of the leading providers of plasma protein biotherapeutic products in the world. It is a pharmaceutical company engaged in the research and development of life-saving biotherapies for the treatment of coagulation disorders, such as hemophilia and von Willebrand diseases. The company additionally manufactures a variety of medicines and drugs for the treatment of immune deficiencies, genetic emphysema, sepsis, severe burns, wounds and heomolytic diseases. It also provides medicines for transplantation, coagulation, immunology and critical care applications. The company supplies products under the Cytogam, Helixate, Humate-P, Monoclate-P, Mononine, Stimate, AlbuRx, Albuminar and Vivaglobin brands. It offers sales, marketing, distribution, online ordering and customer support services. The company maintains CSL Plasma, which is a plasma collection network that operates throughout the United States and Germany. CSL Behring is a part of CSL Limited, which is an Australia-based company that supplies sera and vaccines.

Ortho-McNeil-Janssen Pharmaceuticals offers a range of health care products for the treatment of several infectious diseases, as well as pain management. The company s sister concern Ortho-McNeil, which serves primary care hospitals and other care facilities. Ortho-McNeil s products are available under the DURAGESIC, LEVAQUIN, FLOXIN, NIZORAL and PROPULSID brads. The company provides injections, shampoos, caplets, tablets and capsules. Ortho-McNeil offers the ACIPHEX product, which is used of the treatment of heartburn and other symptoms associated with acid reflux disease. The company additionally provides the DORIBAX product for patients with gram negative infections. Ortho-McNeil undertakes several research and development activities.

AmerisourceBergen is one of the nation's largest pharmaceutical services providers. The company provides branded pharmaceuticals, generic pharmaceuticals, biotech and specialty drugs, over-the-counter remedies and health and beauty aids to independent retail pharmacies, national and regional chains, hospitals, clinics, pharmacy benefit managers, prescription mail order facilities, physician offices and long-term care facilities. AmerisourceBergen operates in two segments: pharmaceutical distribution, which includes the operations of AmerisourceBergen Drug Corporation, Specialty Group and Packaging Group; and PharMerica, which includes the long-term care pharmacy and workers' compensation businesses. The company has more than 14,000 employees. AmerisourceBergen began operations in August of 2001 following the merger of AmeriSource Health Corporation and Bergen Brunswig Corporation. It is one of the largest pharmaceuticals distributors in the United States and has its headquarters in Valley Forge, Pa., and a Western management center in Orange, Calif. R. David Yost has been the chief executive officer of AmerisourceBergen for more than nine years. He has been with the medical and health care company for over 32 years. Yost earned a BS degree from the United States Air Force Academy, and a MBA from the University of California-Los Angeles. AmerisourceBergen has 43 distribution centers providing daily delivery in the United States.